Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05180097
Title Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN | AUS

Facility Status City State Zip Country Details
Austin Hospital RECRUITING Heidelberg Victoria 3084 Australia Details
Tom Baker Cancer Centre RECRUITING Calgary Alberta T2N 4N2 Canada Details
BCCA - Vancouver RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Dr. H. Bliss Murphy Cancer Centre RECRUITING St. John's Newfoundland and Labrador A1B 3V6 Canada Details
QEII Health Sciences Centre RECRUITING Halifax Nova Scotia B3H 1V7 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences RECRUITING Hamilton Ontario L8V 5C2 Canada Details
Verspeeten Family Cancer Centre RECRUITING London Ontario N6A 5W9 Canada Details
Ottawa Hospital Research Institute RECRUITING Ottawa Ontario K1H 8L6 Canada Details
University Health Network RECRUITING Toronto Ontario M5G 2M9 Canada Details
The Jewish General Hospital RECRUITING Montreal Quebec H3T 1E2 Canada Details
The Research Institute of the McGill University RECRUITING Montreal Quebec H4A 3J1 Canada Details
CIUSSS de l'Estrie - Centre hospitalier RECRUITING Sherbrooke Quebec J1H 5N4 Canada Details
Allan Blair Cancer Centre RECRUITING Regina Saskatchewan S4T 7T1 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field